Hisamitsu Pharmaceutical Co., Inc. (4530.T)
JPY 4437.0
(2.05%)
JPY 4437.0
(2.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 61.69 Billion JPY | 11.13% |
| 2022 | 55.51 Billion JPY | 15.71% |
| 2021 | 47.97 Billion JPY | 4.17% |
| 2020 | 46.05 Billion JPY | -18.72% |
| 2019 | 56.66 Billion JPY | 14.8% |
| 2018 | 49.35 Billion JPY | -9.76% |
| 2017 | 54.68 Billion JPY | 10.22% |
| 2016 | 49.61 Billion JPY | -15.7% |
| 2015 | 58.86 Billion JPY | -7.14% |
| 2014 | 63.39 Billion JPY | 14.12% |
| 2013 | 55.54 Billion JPY | 20.21% |
| 2012 | 46.21 Billion JPY | 6.05% |
| 2011 | 43.57 Billion JPY | -18.65% |
| 2010 | 53.56 Billion JPY | -14.4% |
| 2009 | 62.57 Billion JPY | 43.73% |
| 2008 | 43.53 Billion JPY | 21.54% |
| 2007 | 35.82 Billion JPY | -3.65% |
| 2006 | 37.17 Billion JPY | -17.96% |
| 2005 | 45.32 Billion JPY | 53.64% |
| 2004 | 29.49 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 71.97 Billion JPY | 16.66% |
| 2024 Q2 | 74.55 Billion JPY | 3.58% |
| 2023 FY | 61.69 Billion JPY | 11.13% |
| 2023 Q1 | 58.55 Billion JPY | 5.49% |
| 2023 Q2 | 69.19 Billion JPY | 18.17% |
| 2023 Q4 | 61.69 Billion JPY | -2.72% |
| 2023 Q3 | 63.41 Billion JPY | -8.35% |
| 2022 Q3 | 65.05 Billion JPY | 5.57% |
| 2022 Q4 | 55.51 Billion JPY | -14.67% |
| 2022 FY | 55.51 Billion JPY | 15.71% |
| 2022 Q1 | 56.05 Billion JPY | 16.84% |
| 2022 Q2 | 61.62 Billion JPY | 9.93% |
| 2021 Q3 | 50.08 Billion JPY | 2.1% |
| 2021 Q2 | 49.05 Billion JPY | 12.97% |
| 2021 Q1 | 43.42 Billion JPY | -5.72% |
| 2021 Q4 | 47.97 Billion JPY | -4.21% |
| 2021 FY | 47.97 Billion JPY | 4.17% |
| 2020 Q3 | 45.81 Billion JPY | -0.49% |
| 2020 FY | 46.05 Billion JPY | -18.72% |
| 2020 Q1 | 47.37 Billion JPY | -16.38% |
| 2020 Q4 | 46.05 Billion JPY | 0.53% |
| 2020 Q2 | 46.03 Billion JPY | -2.83% |
| 2019 Q3 | 57.74 Billion JPY | 11.22% |
| 2019 FY | 56.66 Billion JPY | 14.8% |
| 2019 Q1 | 46.82 Billion JPY | -5.13% |
| 2019 Q4 | 56.66 Billion JPY | -1.87% |
| 2019 Q2 | 51.91 Billion JPY | 10.88% |
| 2018 FY | 49.35 Billion JPY | -9.76% |
| 2018 Q1 | 50.95 Billion JPY | -6.83% |
| 2018 Q4 | 49.35 Billion JPY | -10.74% |
| 2018 Q3 | 55.29 Billion JPY | 0.96% |
| 2018 Q2 | 54.76 Billion JPY | 7.49% |
| 2017 Q3 | 57.12 Billion JPY | 4.81% |
| 2017 Q1 | 51.68 Billion JPY | 4.15% |
| 2017 FY | 54.68 Billion JPY | 10.22% |
| 2017 Q2 | 54.5 Billion JPY | 5.46% |
| 2017 Q4 | 54.68 Billion JPY | -4.26% |
| 2016 Q2 | 54.14 Billion JPY | -3.64% |
| 2016 Q4 | 49.61 Billion JPY | -8.42% |
| 2016 Q3 | 54.18 Billion JPY | 0.07% |
| 2016 Q1 | 56.18 Billion JPY | -4.54% |
| 2016 FY | 49.61 Billion JPY | -15.7% |
| 2015 Q4 | 58.86 Billion JPY | -7.61% |
| 2015 Q1 | 60.66 Billion JPY | -4.29% |
| 2015 Q2 | 63.39 Billion JPY | 4.49% |
| 2015 FY | 58.86 Billion JPY | -7.14% |
| 2015 Q3 | 63.7 Billion JPY | 0.5% |
| 2014 FY | 63.39 Billion JPY | 14.12% |
| 2014 Q1 | 55.57 Billion JPY | 0.04% |
| 2014 Q4 | 63.39 Billion JPY | 0.26% |
| 2014 Q3 | 63.22 Billion JPY | -1.76% |
| 2014 Q2 | 64.35 Billion JPY | 15.81% |
| 2013 Q3 | 57.33 Billion JPY | -2.14% |
| 2013 Q4 | 55.54 Billion JPY | -3.11% |
| 2013 FY | 55.54 Billion JPY | 20.21% |
| 2013 Q1 | 47.77 Billion JPY | 3.38% |
| 2013 Q2 | 58.58 Billion JPY | 22.63% |
| 2012 FY | 46.21 Billion JPY | 6.05% |
| 2012 Q1 | 46.77 Billion JPY | 7.35% |
| 2012 Q3 | 45.77 Billion JPY | -4.35% |
| 2012 Q4 | 46.21 Billion JPY | 0.96% |
| 2012 Q2 | 47.85 Billion JPY | 2.3% |
| 2011 Q1 | 54.47 Billion JPY | 1.69% |
| 2011 Q2 | 53.57 Billion JPY | -1.64% |
| 2011 Q4 | 43.57 Billion JPY | -14.82% |
| 2011 Q3 | 51.15 Billion JPY | -4.52% |
| 2011 FY | 43.57 Billion JPY | -18.65% |
| 2010 Q3 | 55.77 Billion JPY | -6.14% |
| 2010 Q2 | 59.42 Billion JPY | 4.31% |
| 2010 FY | 53.56 Billion JPY | -14.4% |
| 2010 Q1 | 56.97 Billion JPY | -8.95% |
| 2010 Q4 | 53.56 Billion JPY | -3.96% |
| 2009 Q2 | 68.02 Billion JPY | 75.51% |
| 2009 FY | 62.57 Billion JPY | 43.73% |
| 2009 Q4 | 62.57 Billion JPY | -16.14% |
| 2009 Q3 | 74.61 Billion JPY | 9.69% |
| 2009 Q1 | 38.76 Billion JPY | 0.0% |
| 2008 FY | 43.53 Billion JPY | 21.54% |
| 2007 FY | 35.82 Billion JPY | -3.65% |
| 2006 FY | 37.17 Billion JPY | -17.96% |
| 2005 FY | 45.32 Billion JPY | 53.64% |
| 2004 FY | 29.49 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -146.895% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.213% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 91.789% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 62.463% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -1717.213% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -43.916% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -121.395% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 87.532% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -1124.087% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -100.097% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -55.033% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -98.475% |
| Tsumura & Co. | 132.88 Billion JPY | 53.574% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -55.045% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -363.969% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 77.546% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -39.712% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 12.744% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -31.563% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -780.965% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -142.517% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -657.713% |
| MedRx Co., Ltd | 129 Million JPY | -47724.806% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -1785.205% |
| Solasia Pharma K.K. | 673 Million JPY | -9067.013% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -9457.508% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -96.597% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 62.38% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -6000.223% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 88.226% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -787.385% |